Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center, New York

Department of Neurology, McKnight Brain Institute, Gainesville

Department of Neurology, University of Minnesota, Minneapolis

University of Kansas Medical Center, Kansas City

Department of Neurology, Cedars-Sinai Medical Center, Los Angeles

Brigham and Women's Hospital, Boston

University of Michigan Health System, Ann Arbor

Department of Neurology and Psichiatry, Saint Louis University, St Louis

Saint Luke's Rehabilitation Institute, Spokane

Departement of Neurology, UZ Leuven, Leuven

Cntre de Reference des Maladies Neuromusculaires, Hopital Swynghedauwl, CHU Lille, Lille

Centre de Reference des Neuropathies Peripheriques Rare, Hopital Dupuytren, CHU Limoges, Limoges

Service de Neurologie et du Sommeil, CHU Lyon Sud, Lyon

Centre de Reference des Maladie Neuromusculaires, CHU la Timone, Marseille

Centre de Reference des Maladie Neuromusculaires, Hotel Dieu, CHU de Nantes, Nantes

Service de Neurologie, Hopital Kremlin Bicetre, Paris

Departement of Neurology, Academic Medical Center, Amsterdam

Department of neurology, Hospital Univesitario de Bellvitge, Barcelona

Servicio de Neurologia, Hospital Universitario La Paz, Madrid

Centro de Diagnostico y Tratamiento, Hospital Universitario Virgen del Rocio, Seville

Servicio de Neurologia, Hospital Universitario i Politécnic La Fe, Valencia

University Hospital of Quebec, Québec

Department of Neurology, Salford Royal NHS Foundation Trust, Salford